- Free COVID-19 tests will continue to be available to help protect specific groups including eligible patients and NHS and care staff once the universal testing offer ends after 31 March and next steps for adult social care set out
- Plans in place to enable rapid testing response should a new health threat emerge, such as a new variant of concern emerge
- Vaccines and treatments mean we can transition to managing COVID-19 like other respiratory illnesses, with updated guidance published on 1 April
People at risk of serious illness from COVID-19, and eligible for treatments, will continue to get free tests to use if they develop symptoms, along with NHS and adult social care staff and those in other high-risk settings, Health and Social Care Secretary Sajid Javid announced today (Tuesday 29 March).
Free testing for the general public ends on 1 April as part of the Living with Covid plan which last month set out the government’s strategy to live with and manage the virus.
Although COVID-19 infections and hospitalisations have risen in recent weeks, over 55% of those in hospital that have tested positive are not there with COVID-19 as their primary diagnosis.
Free universal testing has come at a significant cost to the taxpayer, with the testing, tracing and isolation budget costing over £15.7 billion in 2021-22. This was necessary due to the severe risk posed by COVID-19 when the population did not have a high level of protection.
Thanks to the success of the vaccination programme and access to antivirals, alongside natural immunity and increased scientific and public understanding about how to manage risk, the population now has much stronger protection against COVID-19 than at any other point in the pandemic.
This is enabling the country to begin to manage the virus like other respiratory infections.
From 1 April, updated guidance will advise people with symptoms of a respiratory infection, including COVID-19, and a high temperature or who feel unwell, to try stay at home and avoid contact with other people, until they feel well enough to resume normal activities and they no longer have a high temperature. Until 1st of April individuals should continue to follow the current guidance.
From the 1 of April, anyone with a positive COVID-19 test result will be advised to try to stay at home and avoid contact with other people for 5 days, which is when they are most infectious.
Advice will be provided for individuals who need to leave their home when they have symptoms or have tested positive, including avoiding close contact with people with a weakened immune system, wearing a face-covering and avoiding crowded places.
Asymptomatic lateral flow testing will continue from April in some high-risk settings where infection can spread rapidly while prevalence is high. This includes patient-facing staff in the NHS and NHS-commissioned Independent Healthcare Providers, staff in hospices and adult social care services, such as homecare organisations and care homes, a small number of care home visitors who provide personal care, staff in some prisons and places of detention and in high risk domestic abuse refuges and homelessness settings. In addition, testing will be provided for residential SEND, care home staff and residents during an outbreak and for care home residents upon admission. This also includes some staff in prisons and immigration removal centres.
Children and young people who are unwell and have a high temperature should stay at home and avoid contact with other people, where they can. They can go back to school, college or childcare when they no longer have a high temperature, and they are well enough to attend.
The internationally recognised Community Infection Survey delivered through the Office for National Statistics will continue to provide a detailed national surveillance capability in the coming year so the government can respond appropriately to emerging developments such as a new variant of concern or changing levels of population infection. Infections in health and care settings will also be monitored through bespoke studies including the Vivaldi study in residential care homes, the SIREN study in the NHS, and RCGP surveillance in primary care.
The government has retained the ability to enable a rapid testing response should it be needed, such as a new variant of concern.
This includes a stockpile of lateral flow tests and the ability to ramp up testing laboratories and delivery channels.
The government’s Therapeutics Taskforce and Antiviral Taskforce will also be merged into a single unit which will continue to focus on securing access to the most promising treatments for COVID-19.
